Nls Pharmaceutics Ltd (NLSP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NLSP Annual Balance Sheets →
The balance sheet data below highlights changes in Nls Pharmaceutics Ltd's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent2.20
Cash, Cash Equivalents Other2.20
Cash & Short-term Investments4.00
Other Receivables0.00
Derivatives, Collateral, Regulatory, Deferred0.30
Prepaid Expense And Other Assets Current0.98
Total Current Assets3.18
Equipment/Property/Plant Net1.63
Goodwill net1.73
Intangible Assets0.00
Tax Assets, Noncurrent1.67
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent0.73
Total Assets11.45
Liabilities
Accounts Payable0.25
Accrued Liabilities, Current AC0.88
Loans Payable to Bank, Current LO10.36
Other Liabilities, Current3.59
Deferred Liability and Revenue0.06
Total Current Liabilities4.20
Long-term Debt Convertible2.29
Total Long-term Debt2.29
Accrued Income Taxes, Noncurrent1.67
Total Liabilities4.20
Stockholders' Equity
Common Stock Value0.29
Additional Paid In Capital Common Stock93.69
Retained Earnings / Accumulated Deficit-84.89
Accumulated Other Comprehensive Income-1.85
Other Equity-1.84
Common Stockholder's Equity7.25
Preferred Stockholder's Equity0.00
Total Stockholder's Equity7.25
Liabilities & Stockholder's Equity11.45
4 historic quarters locked

Sign in to unlock the full Nls Pharmaceutics Ltd balance sheet history.

About Newcelx Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-049307

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.